Outcomes of heart transplantation for cardiac amyloidosis: Subanalysis of the Spanish registry for heart transplantation

American Journal of Transplantation

Volumn 9, Issue 6, 2009, Pages 1414-1419

  Roig, E ^a   Almenar, L ^b   Gonzalez Vilchez F ^c   Rabago G ^d   Delgado, J ^e   Gomez Bueno M ^f   Crespo Leiro, M G ^g   Arizon J M ^h   De La Fuente, L ⁱ   Manito, N ^j  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g Hospital A Coruna   (Spain)

^h HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^j HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

more..

Author keywords

Cardiac amyloidosis; Heart transplantation; Liver transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GRAFT REJECTION; HEART AMYLOIDOSIS; HEART TRANSPLANTATION; HUMAN; LIVER TRANSPLANTATION; MALE; MORTALITY; ORGAN DONOR; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; SPAIN; TREATMENT FAILURE; TREATMENT INDICATION;

ADULT; AGED; AMYLOID; AMYLOIDOSIS; CARDIOMYOPATHIES; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREALBUMIN; REGISTRIES; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 66249101178     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02643.x     Document Type: Article

References (28)

1. Falk R, Comenzo R, Skinner M. The systemic amyloidosis. N Engl J Med 1997 337 : 898 909.
2. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003 349 : 583 596. (Pubitemid 36951371)
3. Selvanayagam J, Hawkins P, Paul B, Myerson S, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007 50 : 2101 2110. (Pubitemid 350117349)
4. Dubrey S, Burke M, Hawkins P, Banner N. Cardiac transplantation for amyloid heart disease: The United Kingdom experience. J Heart Lung Transplant 2004 23 : 1142 1153. (Pubitemid 39346230)
5. Conner R, Hosenpud J, Norman D, Pantely G, Cobanoglu A, Starr A. Heart transplantation for cardiac amyloidosis: Successful one-year outcome despite recurrence of the disease. J Heart Lung Transplant 1988 7 : 165 167. (Pubitemid 18115745)
6. Hosenpud J, DeMarco T, Frazier O et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation 1991 84 : III338 III343.
7. Hosenpud J, Uretsky B, Griffith B, O'Cinnell J, Olivari M, Valantine H. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: Results of a multicenter survey. J Heart Lung Transplant 1990 9 : 346 350. (Pubitemid 20279759)
8. Fuchs U, Zittermann A, Suhr O et al. Heart transplantation in a 68-year-old patient with senile systemic amyloidosis. Am J Transpl 2005 5 : 1159 1162. (Pubitemid 40571269)
9. Semigran M, Stevenson L, Passeri J, Stone J. Case 37-2007: A 47-year-old man with left ventricular dysfunction after heart transplantation. N Engl J Med 2007 357 : 2286 2297. (Pubitemid 350190761)
10. Sack F, Kristen A, Goldschmidt H et al. Treatment options for severe cardiac amyloidosis: Heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. Eur J Cardio-thoracic Surg 2008 33 : 257 262.
11. Dubrey S, Burke M, Khaghani A, Hawkins P, Yacoub M, Banner N. Long term results of heart transplantation in patients with amyloid heart disease. Heart 2001 85 : 202 207. (Pubitemid 32973594)
12. Aurora P, Boucek M, Christie J et al. Registry of the international society for heart and lung transplantation: Tenth official pediatric lung and heart/lung transplantation Report-2007. J Heart Lung Transplant 2007 26 : 1223 1228. (Pubitemid 350256978)
13. Almenar-Bonet L. (Representing the Spanish cardiac transplant groups). Registro Español de Trasplante Cardiaco. XVIII Informe Oficial de la Sección de Insuficiencia Cardiaca, Trasplante Cardiaco y Otras Alternativas Terapéuticas de la Sociedad Española de Cardiología (1984-2007). Rev Esp Cardiol 2008 61 : 1178 1190.
14. Billingham ME. Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transpl 1981 1 : 25 30.
15. Alloni A, Pellegrini C, Ragni et al. Heart transplantation in patients with amyloidosis: Single-center experience. Transp Proceed 2004 36 : 643 644. (Pubitemid 38534348)
16. Kpodonu J, Massad M, Caines A, Geha A. Outcome of heart transplantation in patients with amyloid cardiomyopathy. J Heart Lung Transplant 2005 24 : 1763 1765. (Pubitemid 41641848)
17. Jaccard A, Moreau P, Leblond V et al. High-dose melphalan versus melphalan plus dexametasona for AL amyloidosis. N Eng J Med 2007 357 : 1083 1093. (Pubitemid 47443213)
18. Comenzo R, Getz M. Autologous stem cell transplantation for primary amyloidosis. Blood 2002 99 : 4276 4282. (Pubitemid 34627192)
19. Gómez-Bueno M, Segovia J, García-Pavía P et al. Cardiac amyloidosis: The importance of a multidisciplinary approach. Rev Esp Cardiol 2009 63 : 630 633.
20. Razonable R, Patel R, Wilhelm M et al. Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis. Am J Transplant 2001 1 : 93 95. (Pubitemid 33681688)
21. Gillmore J, Goodman H, Lachmann H et al. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006 107 : 1227 1229. (Pubitemid 43156329)
22. Perz J, Kristen A, Rahemtulla A et al. Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation. Clin Res Cardiol 2006 95 : 671 674.
23. Lacy M, Dispenzieri A, Hayman S et al. Autologous stem cell transplant after heart transplant for light chain (AL) amyloid cardiomyopathy. J Heart Lung Transplant 2008 27 : 823 829.
24. Hamour I, Lachmann H, Goodman H et al. Heart transplantation for homozygous familial transthyretin (TTR) V122l cardiac amyloidosis. Am J Transplant 2008 8 : 1056 1059.
25. Jacobson D, Pastore R, Yaghoubian R et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997 336 : 466 473. (Pubitemid 27074357)
26. Pilato E, Dell'Amore A, Botta L, Arpesella G. Combined heart and liver transplantation for familial amyloidotic neuropathy. Cardio-Thoracic Sur 2007 32 : 180 182. (Pubitemid 46874959)
27. Grazi G, Cescon M, Salvi F et al. Combined heart and liver transplantation for familial amyloidotic neuropathy: Considerations from the hepatic point of view. Liver Transpl 2003 9 : 986 992. (Pubitemid 37098850)
28. Lachmann H, Goodman H, Gilbertson J et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007 356 : 2361 2371. (Pubitemid 46883770)